Your browser doesn't support javascript.
loading
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib.
Paik, Paul K; Goyal, Ravi K; Cai, Beilei; Price, Mark A; Davis, Keith L; Ansquer, Valerie Derrien; Caro, Nydia; Saliba, Teddy R.
Affiliation
  • Paik PK; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Manhattan, NY 10065, USA.
  • Goyal RK; Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.
  • Cai B; RTI Health Solutions, 3040 E Cornwallis Road, Research Triangle Park, NC 27709, USA.
  • Price MA; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ 07936, USA.
  • Davis KL; RTI Health Solutions, 3040 E Cornwallis Road, Research Triangle Park, NC 27709, USA.
  • Ansquer VD; RTI Health Solutions, 3040 E Cornwallis Road, Research Triangle Park, NC 27709, USA.
  • Caro N; RTI Health Solutions, 3040 E Cornwallis Road, Research Triangle Park, NC 27709, USA.
  • Saliba TR; Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ 07936, USA.
Future Oncol ; 19(3): 217-228, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36749292
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: Future Oncol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies Limits: Humans Language: En Journal: Future Oncol Year: 2023 Type: Article Affiliation country: United States